People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

BACKGROUND: The ability to predict recovery of left ventricular ejection fraction (LVEF) in response to guideline-directed therapy among patients with nonischemic cardiomyopathy is desired. We sought ...

Chest pain or pressure, cold sweat, extreme weakness—you know those heart attack signs. But there are more subtle symptoms ...

scPharmaceuticals Inc. ( NASDAQ: SCPH) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Nick Colangelo - Investor Relations John Tucker - Chief Executive Officer Steve Parsons - Senior ...

That there are key approaches to prevent stroke from ever occurring is a huge step forward for patients and public health. In the past decade, we have seen a plateau in death rates due to stroke, ...

Noninvasive liver fibrosis scores are associated with increased heart failure risk, with FIB-4, NFS, and APRI showing ...

FineHeart, a clinical-stage MedTech company developing innovative medical devices for heart failure, has achieved a major milestone in its ...

Andrew Simpson, CEO of HeartSciences, said, "The inclusion of AI-ECG for reimbursement by CMS represents a significant milestone for commercialization of our products and further validates the ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

Q3 2024 Earnings Call Transcript November 11, 2024 9:00 AM ETCompany ParticipantsVivian Cervantes - IRNestor Jaramillo ...

The exposure-response model is a nonlinear, mixed-effects Emax model that included repeated measurements of RPF for each subject in the study (>200 data points), resulting in a modeled E max (maximum ...

The Mother of God brings healing to a child — and touches the heart of a family. L to R: Eric and Andrea Paul and their son ...